Sectors Covered   Completed Transactions   Testimonials   Principals   M&A Report 
 and Publications 
 Contact Us 












Dynamic Healthcare M&A Database - 4Q07



Return to the Summary Page (4Q07)



Acquiring Party    Natus Medical Incorporated (Nasdaq:BABY), a provider of products for hearing impairment, neurological dysfunction, and newborn care.
Transferring Party    Excel-Tech Ltd. (XLTEK) (Toronto:NRV.TO), a developer of computer-based electro diagnostic systems for neurologic and sleep disorders.
Sector    Diagnostics
Date    November 29, 2007
Analysis
Broadens Natus' product offerings in neurology and advances a goal of of achieveing a $250m annual run-rate by the end of 08. Excel-Tech's products include long-term EEG patient monitoring system for the diagnosis of epilepsy, EMG systems, used in the diagnosis of neuropathies and myopathies, and intra-operative monitoring systems, used during surgical procedures in the OR. Leverages the combined direct sales channels in the U.S. and Canada, and provide new distribution for XLTEK products through the Natus international distribution organization, now operating in over 80 countries. Deal value - $63.6m, on sales $32.8m (1.94X).




The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones.

This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc.


The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.